This map shows the geographic impact of A Barbeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Barbeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Barbeau more than expected).
This network shows the impact of papers produced by A Barbeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Barbeau. The network helps show where A Barbeau may publish in the future.
Co-authorship network of co-authors of A Barbeau
This figure shows the co-authorship network connecting the top 25 collaborators of A Barbeau.
A scholar is included among the top collaborators of A Barbeau based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A Barbeau. A Barbeau is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Barbeau, A, et al.. (1996). URINARY EXCRETION OF A 3-4, DIMETHOXYPHENYLETHYLAMINE-LIKE SUBSTANCE IN PARKINSON'S DISEASE.. PubMed. 22. 469–72.1 indexed citations
3.
Barbeau, A, Naoki Inoue, & T. Cloutier. (1976). Role of manganese in dystonia.. PubMed. 14. 339–52.88 indexed citations
Barbeau, A. (1974). The clinical physiology of side effects in long-term L-DOPA therapy.. PubMed. 5. 347–365.81 indexed citations
8.
Donaldson, Jill, et al.. (1973). [Changes in regional concentrations of cerebral monoamines induced by angiotensin].. PubMed. 102(4). 903–6.1 indexed citations
9.
Küchel, O, et al.. (1973). [The adrenergic nervous system and essential arterial hypertension].. PubMed. 102(4). 812–8.1 indexed citations
10.
Cadotte, M, et al.. (1972). [Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease].. PubMed. 101(5). 893–5.3 indexed citations
11.
Botez, M.I. & A Barbeau. (1971). Role of subcortical structures, and particularly of the thalamus, in the mechanisms of speech and language. A review.. PubMed. 8(2). 300–20.70 indexed citations
12.
Barbeau, A, et al.. (1970). Dopamine and blood pressure.. PubMed. 95. 69–72.1 indexed citations
13.
Dagenais, Gilles R., et al.. (1968). Cryofibrinogenemia and cerebrovascular accident.. PubMed. 98(10). 475–8.5 indexed citations
14.
Barbeau, A, et al.. (1966). [Method of measurement of akinesia].. PubMed. 95(5). 531–5.4 indexed citations
15.
Barbeau, A, et al.. (1965). Effect of 3,4-dimethoxyphenylethylamine injections on the concentration of catecholamines in the rat brain.. PubMed. 24(3). 229–32.3 indexed citations
16.
Barbeau, A, et al.. (1963). [Parkinsonism and cancer].. PubMed. 92. 169–74.8 indexed citations
17.
Barbeau, A & G. Jasmin. (1961). [Determination of urinary 5-hydroxyindolacetic acid in Parkinson's disease].. PubMed. 20. 837–8.2 indexed citations
18.
Barbeau, A, et al.. (1961). An early defect in Wilson's disease.. PubMed. 20. 25–35.2 indexed citations
Barbeau, A, et al.. (1958). [Bilateral pheochromocytoma: case report and review of the literature].. PubMed. 87(2). 165–78.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.